144 related articles for article (PubMed ID: 16720317)
1. Angiogenic switch in Barrett's adenocarcinoma: the role of vascular endothelial growth factor.
Islam A; Banerjee S; Kambhampati S; Baranda J; Banerjee S; Weston AP; Saxena NK; Banerjee SK
Front Biosci; 2006 Sep; 11():2336-48. PubMed ID: 16720317
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets for treatment of Barrett's esophagus.
Feagins LA; Souza RF
Dis Esophagus; 2005; 18(2):75-86. PubMed ID: 16053481
[TBL] [Abstract][Full Text] [Related]
3. Incipient angiogenesis in Barrett's epithelium and lymphangiogenesis in Barrett's adenocarcinoma.
Auvinen MI; Sihvo EI; Ruohtula T; Salminen JT; Koivistoinen A; Siivola P; Rönnholm R; Rämö JO; Bergman M; Salo JA
J Clin Oncol; 2002 Jul; 20(13):2971-9. PubMed ID: 12089227
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor expression and neovascularization in Barrett's carcinoma.
Möbius C; Stein HJ; Becker I; Feith M; Theisen J; Gais P; Jütting U; Siewert JR
World J Surg; 2004 Jul; 28(7):675-9. PubMed ID: 15175900
[TBL] [Abstract][Full Text] [Related]
5. Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
Brabender J; Lord RV; Danenberg KD; Metzger R; Schneider PM; Park JM; Salonga D; Groshen S; Tsao-Wei DD; DeMeester TR; Hölscher AH; Danenberg PV
J Surg Res; 2001 Aug; 99(2):301-6. PubMed ID: 11469901
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic markers, neovascularization and malignant deformation of Barrett's esophagus.
Wilson KT
Dis Esophagus; 2002; 15(1):16-21. PubMed ID: 12060038
[TBL] [Abstract][Full Text] [Related]
7. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
8. Changes in esophageal motility after porfimer sodium photodynamic therapy for Barrett's dysplasia and mucosal carcinoma.
Shah AK; Wolfsen HC; Hemminger LL; Shah AA; DeVault KR
Dis Esophagus; 2006; 19(5):335-9. PubMed ID: 16984528
[TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus: the long and the short of it.
Lewis JD
Gastroenterology; 2000 Oct; 119(4):1165-6. PubMed ID: 11040204
[No Abstract] [Full Text] [Related]
10. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
[TBL] [Abstract][Full Text] [Related]
11. Animal Models of Barrett's Esophagus and Esophageal Adenocarcinoma-Past, Present, and Future.
Kapoor H; Lohani KR; Lee TH; Agrawal DK; Mittal SK
Clin Transl Sci; 2015 Dec; 8(6):841-7. PubMed ID: 26211420
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor in esophageal cancer.
Kleespies A; Guba M; Jauch KW; Bruns CJ
J Surg Oncol; 2004 Aug; 87(2):95-104. PubMed ID: 15282704
[TBL] [Abstract][Full Text] [Related]
13. Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study.
Corley DA; Kubo A; Levin TR; Habel L; Zhao W; Leighton P; Rumore G; Quesenberry C; Buffler P; Block G
Am J Gastroenterol; 2008 Dec; 103(12):2997-3004. PubMed ID: 18853987
[TBL] [Abstract][Full Text] [Related]
14. Barrett's mucosa: remodelling by the microenvironment.
Harrison RF; Perry I; Jankowski JA
J Pathol; 2000 Sep; 192(1):1-3. PubMed ID: 10951392
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression.
Couvelard A; Paraf F; Gratio V; Scoazec JY; Hénin D; Degott C; Fléjou JF
J Pathol; 2000 Sep; 192(1):14-8. PubMed ID: 10951394
[TBL] [Abstract][Full Text] [Related]
16. The Role of Acid Suppression in Barrett's Esophagus.
Elias PS; Castell DO
Am J Med; 2017 May; 130(5):525-529. PubMed ID: 28159599
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett's esophagus.
Wolfsen HC
Dig Dis; 2002; 20(1):5-17. PubMed ID: 12145415
[TBL] [Abstract][Full Text] [Related]
18. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
Burnat G; Rau T; Elshimi E; Hahn EG; Konturek PC
Scand J Gastroenterol; 2007 Dec; 42(12):1460-5. PubMed ID: 17852856
[TBL] [Abstract][Full Text] [Related]
19. [Molecular events associated with Barrett's oesophagus].
Nakajima H; Omura K
Nihon Rinsho; 2005 Aug; 63(8):1362-5. PubMed ID: 16101222
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies.
Kleespies A; Bruns CJ; Jauch KW
Onkologie; 2005 May; 28(5):281-8. PubMed ID: 15867486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
